Insulet
PODD
#1317
Rank
HK$130.09 B
Marketcap
HK$1,848
Share price
-1.15%
Change (1 day)
-4.23%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: HK$130.09 Billion

As of March 2026 Insulet has a market cap of HK$130.09 Billion. This makes Insulet the world's 1317th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$130.09 B-17.7%
2025HK$158.08 B9.49%
2024HK$144.37 B22.01%
2023HK$118.33 B-25.92%
2022HK$159.74 B11.64%
2021HK$143.08 B9.52%
2020HK$130.64 B56.32%
2019HK$83.57 B127.34%
2018HK$36.76 B17.2%
2017HK$31.36 B86.95%
2016HK$16.77 B0.53%
2015HK$16.69 B-17.02%
2014HK$20.11 B27.42%
2013HK$15.78 B98.46%
2012HK$7.95 B14.76%
2011HK$6.93 B26.46%
2010HK$5.48 B31.12%
2009HK$4.18 B173.37%
2008HK$1.52 B-67.41%
2007HK$4.69 B

End of Day market cap according to different sources

On Mar 12th, 2026 the market cap of Insulet was reported to be:

HK$130.09 Billion
by Nasdaq info icon info icon
HK$130.09 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.566 T 3,409.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.471 T 1,030.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$878.25 B 575.07%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$6.847 T 5,163.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
HK$11.16 B-91.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$24.89 B-80.87%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$199.25 B 53.16%๐Ÿ‡บ๐Ÿ‡ธ USA